View in EDS

FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.

Saved in:
Bibliographic Details
Title: FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.
Authors: Pasupuleti SK; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA., Rangaraju S; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Hematology/Oncology at the Kirklin Clinic University of Alabama Birmingham, Birmingham, AL, USA., Layer J; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Padam KSR; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA., Cripe LD; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Sayar H; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Sargent KJ; IU Health Partners, Indianapolis, IN, USA., Weisenbach J; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Indiana University School of Medicine, Indianapolis, IN, USA., Konig H; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Salman H; Indiana Cancer Research Center, Brown Center for Immunotherapy, Indianapolis, IN, USA., Ramdas B; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA., Palam LR; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA., Mayo LD; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA., Khan I; Northwestern University School of Medicine, Chicago, IL, USA., Davé UP; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.; Veterans Affairs Medical Center, Indianapolis, IN, USA., Boswell HS; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.; Veterans Affairs Medical Center, Indianapolis, IN, USA., Kapur R; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA. rkapur@iu.edu.; Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN, USA. rkapur@iu.edu.
Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Feb 26; Vol. 10 (1). Date of Electronic Publication: 2026 Feb 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41748936
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pasupuleti+SK%22">Pasupuleti SK</searchLink>; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Rangaraju+S%22">Rangaraju S</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Hematology/Oncology at the Kirklin Clinic University of Alabama Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Layer+J%22">Layer J</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Padam+KSR%22">Padam KSR</searchLink>; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Cripe+LD%22">Cripe LD</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sayar+H%22">Sayar H</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sargent+KJ%22">Sargent KJ</searchLink>; IU Health Partners, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Weisenbach+J%22">Weisenbach J</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Konig+H%22">Konig H</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Salman+H%22">Salman H</searchLink>; Indiana Cancer Research Center, Brown Center for Immunotherapy, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Ramdas+B%22">Ramdas B</searchLink>; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Palam+LR%22">Palam LR</searchLink>; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Mayo+LD%22">Mayo LD</searchLink>; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Khan+I%22">Khan I</searchLink>; Northwestern University School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Davé+UP%22">Davé UP</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.; Veterans Affairs Medical Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Boswell+HS%22">Boswell HS</searchLink>; Indiana University and Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.; Veterans Affairs Medical Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Kapur+R%22">Kapur R</searchLink>; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA. rkapur@iu.edu.; Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN, USA. rkapur@iu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2026 Feb 26; Vol. 10 (1). <i>Date of Electronic Publication: </i>2026 Feb 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41748936
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-026-01332-1
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pasupuleti SK
      – PersonEntity:
          Name:
            NameFull: Rangaraju S
      – PersonEntity:
          Name:
            NameFull: Layer J
      – PersonEntity:
          Name:
            NameFull: Padam KSR
      – PersonEntity:
          Name:
            NameFull: Cripe LD
      – PersonEntity:
          Name:
            NameFull: Sayar H
      – PersonEntity:
          Name:
            NameFull: Sargent KJ
      – PersonEntity:
          Name:
            NameFull: Weisenbach J
      – PersonEntity:
          Name:
            NameFull: Konig H
      – PersonEntity:
          Name:
            NameFull: Salman H
      – PersonEntity:
          Name:
            NameFull: Ramdas B
      – PersonEntity:
          Name:
            NameFull: Palam LR
      – PersonEntity:
          Name:
            NameFull: Mayo LD
      – PersonEntity:
          Name:
            NameFull: Khan I
      – PersonEntity:
          Name:
            NameFull: Davé UP
      – PersonEntity:
          Name:
            NameFull: Boswell HS
      – PersonEntity:
          Name:
            NameFull: Kapur R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 02
              Text: 2026 Feb 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1